AstraZeneca PLC (AZN)
NASDAQ: AZN · IEX Real-Time Price · USD
78.13
-0.39 (-0.50%)
At close: Jul 26, 2024, 4:00 PM
78.90
+0.77 (0.99%)
After-hours: Jul 26, 2024, 7:59 PM EDT

AstraZeneca Revenue

AstraZeneca had revenue of $12.94B in the quarter ending June 30, 2024, with 13.33% growth. This brings the company's revenue in the last twelve months to $49.13B, up 10.45% year-over-year. In the year 2023, AstraZeneca had annual revenue of $45.81B with 3.29% growth.

Revenue (ttm)
$49.13B
Revenue Growth
+10.45%
P/S Ratio
4.93
Revenue / Employee
$546,529
Employees
89,900
Market Cap
242.25B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202345.81B1.46B3.29%
Dec 31, 202244.35B6.93B18.53%
Dec 31, 202137.42B10.80B40.58%
Dec 31, 202026.62B2.23B9.16%
Dec 31, 201924.38B2.29B10.38%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 379.49B
Johnson & Johnson 78.71B
Merck & Co. 61.40B
AbbVie 54.40B
Novartis AG 48.86B
Thermo Fisher 42.49B
Abbott Laboratories 40.33B
Novo Nordisk 35.35B
Revenue Rankings